Evidence map›Paper›PMID 35132820›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2022

Reply.

Ailing Lu, Guangxun Meng

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Ailing LuThe Center for Microbes, Development and Health CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai Chinese Academy of Sciences and the University of Chinese Academy of Sciences, Shanghai, China.
Guangxun MengThe Center for Microbes, Development and Health CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai Chinese Academy of Sciences and the University of Chinese Academy of Sciences, Shanghai, China.ORCID 0000-0003-4634-4661

Funding

National Key Basic Research Program 2018YFA0507300Natural Science Foundation of China 81830049Shanghai Research Leader Program 20XD1403900
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35132820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.